pone.0225861.g004.tif (178.09 kB)

Expected per capita TB-associated mortality.

Download (178.09 kB)
posted on 30.01.2020, 18:40 by Ashley A. DeNegre, Kellen Myers, Nina H. Fefferman

Our analysis indicates that HIV/AIDS patients not receiving HAART are, individually, twice as at risk of TB-related mortality as those who are HAART treated. This result occurred in both Indonesia and Swaziland, regardless of both initial TB prevalence and the proportion of HIV/AIDS patients receiving chemoprophylaxis.